Latest Trials Latest NewsFAQ

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department

Not Applicable

Completed

Conditions: Opiate Addiction

Interventions: Behavioral: Brief Negotiation Interview (BNI)
Drug: Buprenorphine Initiation

First Posted Date: 2009-06-04

Last Posted Date: 2020-03-24

Lead Sponsor: Yale University

Target Recruit Count: 329

Registration Number: NCT00913770

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications

Completed

Conditions: Infertility

First Posted Date: 2009-05-15

Last Posted Date: 2018-02-07

Lead Sponsor: Yale University

Target Recruit Count: 264

Registration Number: NCT00902382

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸
Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States
🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

and more 10 locations

Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk

Phase 2

Completed

Conditions: Tobacco Use Cessation
Alcohol-related Disorders

Interventions: Behavioral: behavioral counseling plus contingency management

First Posted Date: 2009-03-13

Last Posted Date: 2020-04-03

Lead Sponsor: Yale University

Target Recruit Count: 151

Registration Number: NCT00861146

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

The Impact of Active Nurse Participation on Adenoma Detection During Routine Colonoscopy

Not Applicable

Completed

Conditions: Adenoma

Interventions: Procedure: nurse observation during colonoscope withdrawal

First Posted Date: 2009-03-11

Last Posted Date: 2015-01-22

Lead Sponsor: Yale University

Target Recruit Count: 500

Registration Number: NCT00859625

Locations: 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

Varenicline for Smoking Cessation in Heavy Drinking Smokers

Phase 2

Completed

Conditions: Smoking
Nicotine Dependence
Heavy Drinking

Interventions: Drug: Short-term Varenicline Pretreatment
Drug: Extended Varenicline Pretreatment

First Posted Date: 2009-03-11

Last Posted Date: 2021-08-13

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT00860028

Buprenorphine/Raltegravir Pharmacokinetic Interaction Study

Not Applicable

Completed

Conditions: HIV Infection
HIV Infections

Interventions: Drug: Raltegravir

First Posted Date: 2009-03-10

Last Posted Date: 2012-11-21

Lead Sponsor: Yale University

Target Recruit Count: 12

Registration Number: NCT00858962

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment

Completed

Conditions: HIV Positive
Opioid Dependence
Opioid Agonist Treatment
HIV Infections

First Posted Date: 2009-03-06

Last Posted Date: 2013-07-22

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT00857350

Locations: 🇺🇸
Yale University Hospital, New Haven, Connecticut, United States

Changing Lifestyles for Better Health

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Behavioral: Intensive Lifestyle Intervention

First Posted Date: 2009-02-20

Last Posted Date: 2022-05-04

Lead Sponsor: Yale University

Target Recruit Count: 130

Registration Number: NCT00848757

Locations: 🇺🇸
Fair Haven Community Health Center, New Haven, Connecticut, United States

Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity

Phase 4

Terminated

Conditions: Pediatric Obesity
Insulin Resistance
Impaired Glucose Tolerance
Cardiovascular Disease

Interventions: Drug: Acarbose

First Posted Date: 2009-02-18

Last Posted Date: 2013-05-01

Lead Sponsor: Yale University

Target Recruit Count: 23

Registration Number: NCT00846521

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults

Phase 4

Withdrawn

Conditions: Obesity
Cardiovascular Disease
Insulin Resistance
Impaired Glucose Tolerance

Interventions: Drug: Exenatide

First Posted Date: 2009-02-18

Last Posted Date: 2012-12-11

Lead Sponsor: Yale University

Registration Number: NCT00845559

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy